-
Fund Dashboard
- Holdings
Janus Henderson Global Life Sciences Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
LLY Eli Lilly and Company | 427.93 mm | 554.32 k shares | 8.96 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 315.60 mm | 623.89 k shares | 6.60 | Common equity | Long | USA |
Novo Nordisk A/S SER'B'DKK0.1
|
174.61 mm | 2.03 mm shares | 3.65 | Common equity | Long | Denmark |
AZN AstraZeneca PLC | 174.46 mm | 1.34 mm shares | 3.65 | Common equity | Long | UK |
JNJ Johnson & Johnson | 145.82 mm | 1.01 mm shares | 3.05 | Common equity | Long | USA |
AMGN Amgen Inc. | 137.10 mm | 526.02 k shares | 2.87 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 135.03 mm | 1.51 mm shares | 2.83 | Common equity | Long | USA |
ABT Abbott Laboratories | 131.34 mm | 1.16 mm shares | 2.75 | Common equity | Long | USA |
Sanofi EUR2
|
129.97 mm | 1.34 mm shares | 2.72 | Common equity | Long | France |
ABBV AbbVie Inc. | 124.87 mm | 702.68 k shares | 2.61 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 116.91 mm | 1.18 mm shares | 2.45 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 113.10 mm | 280.87 k shares | 2.37 | Common equity | Long | USA |
Argenx SE SPON ADR EACH REP 1 ORD SHS | 109.99 mm | 178.84 k shares | 2.30 | Long | USA | |
TMO Thermo Fisher Scientific Inc. | 107.38 mm | 206.40 k shares | 2.25 | Common equity | Long | USA |
NVS Novartis AG | 101.80 mm | 1.05 mm shares | 2.13 | Long | USA | |
ISRG Intuitive Surgical, Inc. | 95.23 mm | 182.45 k shares | 1.99 | Common equity | Long | USA |
DHR Danaher Corporation | 88.86 mm | 387.10 k shares | 1.86 | Common equity | Long | USA |
SYK Stryker Corporation | 86.00 mm | 238.86 k shares | 1.80 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 77.28 mm | 635.58 k shares | 1.62 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 66.92 mm | 817.45 k shares | 1.40 | Common equity | Long | USA |
Teva Pharmaceutical Industries Ltd. SPON ADS EACH REP 1 ORD SHS | 64.83 mm | 2.94 mm shares | 1.36 | Long | USA | |
ASND Ascendis Pharma A/S | 63.33 mm | 460.02 k shares | 1.33 | Long | USA | |
GMED Globus Medical, Inc. | 60.66 mm | 733.37 k shares | 1.27 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 58.63 mm | 189.99 k shares | 1.23 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 58.00 mm | 1.33 mm shares | 1.21 | Common equity | Long | USA |
Roche Holding AG GENUSSCHEINE NPV | 57.91 mm | 206.82 k shares | 1.21 | Preferred equity | Long | Switzerland |
HCA HCA Healthcare, Inc. | 56.05 mm | 186.75 k shares | 1.17 | Common equity | Long | USA |
ELV Elevance Health Inc. | 54.44 mm | 147.57 k shares | 1.14 | Common equity | Long | USA |
MCK McKesson Corporation | 51.20 mm | 89.84 k shares | 1.07 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 47.80 mm | 135.47 k shares | 1.00 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 45.50 mm | 1.64 mm shares | 0.95 | Common equity | Long | USA |
BHVN Biohaven Ltd. | 43.59 mm | 1.17 mm shares | 0.91 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 41.95 mm | 933.30 k shares | 0.88 | Common equity | Long | USA |
LNTH Lantheus Holdings, Inc. | 40.31 mm | 450.61 k shares | 0.84 | Common equity | Long | USA |
PEN Penumbra, Inc. | 40.05 mm | 168.66 k shares | 0.84 | Common equity | Long | USA |
HUM Humana Inc. | 38.16 mm | 150.40 k shares | 0.80 | Common equity | Long | USA |
MDT Medtronic plc | 36.78 mm | 460.42 k shares | 0.77 | Common equity | Long | USA |
ZTS Zoetis Inc. | 36.65 mm | 224.95 k shares | 0.77 | Common equity | Long | USA |
EW Edwards Lifesciences Corporation | 35.24 mm | 476.01 k shares | 0.74 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 35.01 mm | 1.20 mm shares | 0.73 | Common equity | Long | USA |
COR Cencora | 34.35 mm | 152.89 k shares | 0.72 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 33.28 mm | 1.41 mm shares | 0.70 | Common equity | Long | USA |
COO The Cooper Companies, Inc. | 32.10 mm | 349.13 k shares | 0.67 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 31.53 mm | 762.42 k shares | 0.66 | Common equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 29.93 mm | 161.48 k shares | 0.63 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 28.86 mm | 539.05 k shares | 0.60 | Common equity | Long | USA |
TFX Teleflex Incorporated | 28.53 mm | 160.30 k shares | 0.60 | Common equity | Long | USA |
ILMN Illumina, Inc. | 28.01 mm | 209.58 k shares | 0.59 | Common equity | Long | USA |
AVDL Avadel Pharmaceuticals plc | 26.71 mm | 2.54 mm shares | 0.56 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 25.82 mm | 336.67 k shares | 0.54 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 23.37 mm | 851.83 k shares | 0.49 | Common equity | Long | USA |
Zai Lab Ltd. ADS EACH REP 1 ORD SHS | 22.91 mm | 874.72 k shares | 0.48 | Long | USA | |
GILD Gilead Sciences, Inc. | 21.70 mm | 234.94 k shares | 0.45 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 21.59 mm | 4.26 mm shares | 0.45 | Common equity | Long | USA |
ETNB 89bio, Inc. | 21.59 mm | 2.76 mm shares | 0.45 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 20.99 mm | 816.64 k shares | 0.44 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 20.85 mm | 461.96 k shares | 0.44 | Common equity | Long | USA |
CNC Centene Corporation | 19.41 mm | 320.38 k shares | 0.41 | Common equity | Long | USA |
STE STERIS plc | 19.16 mm | 93.22 k shares | 0.40 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 18.81 mm | 704.48 k shares | 0.39 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 18.48 mm | 135.40 k shares | 0.39 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 18.38 mm | 677.67 k shares | 0.38 | Long | USA | |
ALNY Alnylam Pharmaceuticals, Inc. | 17.70 mm | 75.22 k shares | 0.37 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 17.47 mm | 341.69 k shares | 0.37 | Common equity | Long | USA |
Janus Henderson Cash Liquidity Fund LLC
|
17.34 mm | 17.34 mm shares | 0.36 | Common equity | Long | USA |
SHC Sotera Health Company | 16.67 mm | 1.22 mm shares | 0.35 | Common equity | Long | USA |
NEO NeoGenomics, Inc. | 16.11 mm | 977.29 k shares | 0.34 | Common equity | Long | USA |
HOYA Corp. NPV
|
16.08 mm | 129.40 k shares | 0.34 | Common equity | Long | Japan |
DXCM DexCom, Inc. | 16.06 mm | 206.50 k shares | 0.34 | Common equity | Long | USA |
ICLR ICON Public Limited Company | 15.27 mm | 72.83 k shares | 0.32 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 15.09 mm | 463.64 k shares | 0.32 | Long | USA | |
RYTM Rhythm Pharmaceuticals, Inc. | 14.37 mm | 256.63 k shares | 0.30 | Common equity | Long | USA |
Takeda Pharmaceutical Co Ltd. NPV
|
13.97 mm | 526.84 k shares | 0.29 | Common equity | Long | Japan |
CYTK Cytokinetics, Incorporated | 13.94 mm | 296.33 k shares | 0.29 | Common equity | Long | USA |
INSM Insmed Incorporated | 13.94 mm | 201.85 k shares | 0.29 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 13.39 mm | 341.64 k shares | 0.28 | Common equity | Long | USA |
ALGN Align Technology, Inc. | 13.17 mm | 63.16 k shares | 0.28 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 12.90 mm | 1.37 mm shares | 0.27 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 11.11 mm | 144.41 k shares | 0.23 | Common equity | Long | USA |
GERN Geron Corporation | 10.60 mm | 2.99 mm shares | 0.22 | Common equity | Long | USA |
IQV IQVIA Holdings Inc. | 10.27 mm | 52.25 k shares | 0.21 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 10.09 mm | 222.67 k shares | 0.21 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 9.59 mm | 550.54 k shares | 0.20 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 9.11 mm | 317.63 k shares | 0.19 | Common equity | Long | USA |
IMNM Immunome, Inc. | 8.87 mm | 835.44 k shares | 0.19 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 8.60 mm | 683.86 k shares | 0.18 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 7.95 mm | 550.98 k shares | 0.17 | Common equity | Long | USA |
Bicara Therapeutics
|
7.63 mm | 437.83 k shares | 0.16 | Common equity | Long | USA |
HeartFlow Inc - Series F | 6.15 mm | 1.93 mm shares | 0.13 | Preferred equity | Long | USA |
Shoreline Biosciences Inc | 5.64 mm | 747.19 k shares | 0.12 | Preferred equity | Long | USA |
Curevo Inc | 5.33 mm | 2.03 mm shares | 0.11 | Preferred equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 5.03 mm | 902.96 k shares | 0.11 | Common equity | Long | USA |
Sonoma Biotherapeutics Inc - Series B | 4.81 mm | 1.26 mm shares | 0.10 | Preferred equity | Long | USA |
LXEO Lexeo Therapeutics, Inc. Common Stock | 4.49 mm | 682.04 k shares | 0.09 | Common equity | Long | USA |
Attralus Inc | 3.71 mm | 669.94 k shares | 0.08 | Preferred equity | Long | USA |
Element Biosciences Inc | 3.52 mm | 425.02 k shares | 0.07 | Preferred equity | Long | USA |
Magnolia Medical Technologies | 3.10 mm | 1.82 mm shares | 0.06 | Preferred equity | Long | USA |
Asher Biotherapeutics - Series C | 3.00 mm | 2.58 mm shares | 0.06 | Preferred equity | Long | USA |
Sonoma Biotherapeutics Inc - Series B-1 | 2.56 mm | 669.43 k shares | 0.05 | Preferred equity | Long | USA |
Freenome Holdings Inc - Series D | 1.91 mm | 342.80 k shares | 0.04 | Preferred equity | Long | USA |
Freenome Holdings Inc - Series C | 1.87 mm | 337.47 k shares | 0.04 | Preferred equity | Long | USA |
Curevo Inc. Series SAFE | 1.86 mm | 186.18 mm shares | 0.04 | Preferred equity | Long | USA |
Asher Biotherapeutics Inc | 1.41 mm | 1.21 mm shares | 0.03 | Preferred equity | Long | USA |
TwinStrand Biosciences Inc | 1.38 mm | 344.31 k shares | 0.03 | Preferred equity | Long | USA |
BCAX Bicara Therapeutics Inc. Common Stock | 757.04 k | 43.46 k shares | 0.02 | Common equity | Long | USA |
Magnolia Medical Technologies | 384.51 k | 384.51 k principal | 0.01 | Debt | Long | USA |
Janus Henderson Cash Collateral Fund
|
235.53 k | 235.53 k shares | 0.00 | Common equity | Long | USA |
Royal Bank of Canada | 58.88 k | 58.88 k principal | 0.00 | Short-term investment vehicle | Long | USA |
Magnolia Medical Technologies
|
37.75 | 37.75 k shares | 0.00 | Common equity | Long | USA |
CMTA Clementia Pharmaceuticals Inc. | 0.87 | 874.31 k shares | 0.00 | Long | USA | |
Magnolia Medical Technologies
|
0 | 1.00 shares | 0.00 | Common equity | Long | USA |